BridgeBio Pharma (BBIO) Dividends Paid - Common (2019)
BridgeBio Pharma recorded quarterly Dividends Paid - Common of $54.0 million in Q3 2019, up 5317.65% quarter-over-quarter from $997000.0 in Q1 2019.
BridgeBio Pharma's Dividends Paid - Common history runs 1 years deep, the most recent figure standing at $54.0 million for Q3 2019.
- In Q3 2019, Dividends Paid - Common changed N/A year-over-year to $54.0 million; the TTM figure through Dec 2019 stood at $55.0 million (changed N/A YoY), while the FY2020 annual figure was $5.0 million, down 90.91% from the prior year.
- Dividends Paid - Common came in at $54.0 million for Q3 2019 at BridgeBio Pharma, up from $997000.0 in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $54.0 million in Q3 2019 to a low of $997000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 97.80 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 54.01 Mn |
| Sep 30, 2019 | 54.01 Mn |
| Mar 31, 2019 | 997,000.00 |
| Mar 31, 2019 | 997,000.00 |